Abstract
Hereditary diffuse gastric cancer (HDGC) is an autosomal dominantly inherited syndrome attributed to mutations of the E-cadherin gene, CDH1. There is no proven effective screening for early HDGC, and symptomatic disease is almost universally fatal. The only available effective option for CDH1 carriers is prophylactic total gastrectomy, but the variable age of onset of HDGC and the reduced penetrance (about 70%) of the CDHI gene further complicate patients' decision making. © 2008 Elsevier Inc. All rights reserved.
Cite
CITATION STYLE
Lynch, H. T., Silva, E., Wirtzfeld, D., Hebbard, P., Lynch, J., & Huntsman, D. G. (2008, August). Hereditary Diffuse Gastric Cancer: Prophylactic Surgical Oncology Implications. Surgical Clinics of North America. https://doi.org/10.1016/j.suc.2008.04.006
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.